InvestorsHub Logo
Followers 241
Posts 12376
Boards Moderated 0
Alias Born 08/14/2003

Re: Scott999 post# 31038

Friday, 04/03/2020 11:50:11 PM

Friday, April 03, 2020 11:50:11 PM

Post# of 44784
I know little about Cellularity, as I understand it, we have far greater manufacturing capability, but I'd like to know if the product they're using is already in the clinic for something else, and if so, how far advanced.

In that both of our products are in Phase 3 Trials they've clearly proven themselves safe, and have efficacy worthy of running Phase 3 Trials. I believe that should put us in the lead, even if they're first to dose in the U.S. We're dosing in Israel, and may be in Germany, or will be soon.

If you look at the curves, by mid April we'll be near the peak in most of the forecast curves, basically from what I've seen by June the numbers really come down substantially. If we really want to cut the number of deaths, if initial trials look good, we need to get the worlds govts. to go for treatment with it by May. Here's a link to the best data I've seen for the U.S.

https://covid19.healthdata.org/projections

Our drug won't prevent getting infected with the disease, but if it's effective it can greatly reduce the deaths, and should greatly diminish the need to put people on regulators.

Gary